Webinar banner
Q&A Conference Call with the CEO - InSitu Biologics
As a prospective investor we invite you to join InSitu Biologic's CEO Jim Segermark for a conference call to answer your questions.

Jim will be available to address your questions regarding our Matrix BioHydrogel, and our pre-clinical stage, long-lasting and long-acting non-opiate painkiller, AnestaGel™ & AniGel™ as well as the Regulation A+ offering and making your online investment.

This format allows for you to interact as much or as little as you’d like and you can even just simply listen in.
Please choose only one webinar to attend.
Time shows in
Webinar logo
* Required information


Jim Segermark
Jim has been the founder, inventor, investor, and owner operator in many med-tech ventures. Jim began working on the Matrix technology in 2007 and co-founded InSitu Biologics in 2014. Jim is an inventor on over 40 issued patents for medical products, and specializes in the total enterprise of bringing proprietary products from “just an idea” through design, scaled up manufacturing, and “to the patient”. Jim earned his Bachelor of Science from Carroll University in Waukesha, Wisconsin and his MBA from Cardinal Stritch University in Milwaukee.